The Biotech Growth Trust PLC (BIOG)

Category Sector Equity Biotechnology

This investment trust can be held in an Investment ISA, SIPP and Investment Account

Sell

938.00p

Buy

951.00p

arrow-down-38.00p (-3.86%)

Discount/Premium

-5.75%

Estimated NAV

1,044.06p

Prices updated at 15 Nov 2024, 18:39 GMT

Prices minimum 15 mins delay

Prices in GBX

Investment objective

The Company seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.

FTSE All-Share

-0.11%

LSE

Important documents: Please ensure that you have read the Key Information Document/Technical Guide , Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Company name

Frostrow Capital LLP

Legal structure

Closed Ended Investment Company

Domicile

United Kingdom

Fiscal year end

31 Mar 2025

Launch date

23 Jun 1997

Lead manager

Geoffrey Hsu

Lead manager start date

19 May 2005

Lead fund manager biography

Hsu joined OrbiMed in 2002 as a biotechnology analyst. Prior to joining OrbiMed, he worked as a financial analyst in the healthcare investment banking group at Lehman Brothers. Hsu has earned the right to use the Chartered Financial Analyst designation.

Head office

25 Southampton Buildings

London

United Kingdom

WC2A 1AL

+44 (0) 203 0084910

Company website

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.